[Cardiac pacemaker therapy for optimizing brain circulation. A possible prevention for cerebrovascular diseases?]

A Hagendorff1, C Dettmers, W Jung

  • 1Medizinische Universitätsklinik und Poliklinik, Leipzig. hagendorff@gmx.net

Insights

Pacemaker therapy can effectively treat cognitive impairment and dizziness caused by reduced cardiac output and cerebral blood flow in patients with impaired cerebral autoregulation.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Devices

Background:

  • A 78-year-old patient presented with dizziness, cognitive decline, fatigue, and syncope.
  • Pre-existing conditions included hypertensive heart disease, reduced left ventricular function, and ventricular ectopia (Lown IVb).

Observation:

  • Cerebral blood flow autoregulation appeared impaired, with a correlation between cardiac output and cerebral blood flow.
  • Computed tomography revealed minimal cerebral atrophy, with no evidence of arterial stenosis or intracranial disease.

Findings:

  • Permanent pacemaker implantation resolved the patient's symptoms, improving cognitive function and eliminating syncope.
  • Recurrence of symptoms during atrial fibrillation (120/min) was linked to decreased cardiac output (4.0 L/min) and cerebral blood flow (35 mL/100 g/min).
  • Restoration of sinus rhythm led to increased cardiac output and cerebral blood flow, resolving symptoms.

Implications:

  • Reduced cardiac function and output can significantly impair cerebral blood flow in patients with compromised cerebral autoregulation.
  • This impairment can manifest as cognitive deficits and neurological symptoms.
  • Pacemaker therapy presents a viable therapeutic option for managing such conditions.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...